Purdue Pharma spends $134M on lawyers during first 9 months of bankruptcy

Purdue Pharma has spent $134 million on lawyers and advisers helping to address its role in the opioid crisis, according to The Wall Street Journal.

The drugmaker filed for bankruptcy in September 2019 to resolve thousands of lawsuits accusing it of fueling the opioid crisis, primarily by flooding communities with its highly addictive narcotic OxyContin. So far, Purdue's abundant legal spending has not lessened its litigation burden, as state officials and local authorities have rejected the drugmaker's settlement offers.

Purdue is owned by the Sackler family, who is also being sued for allegedly fueling the opioid crisis. They have offered a settlement of $3 billion and other concessions to the families of opioid victims. 

"Every day and every dollar spent in bankruptcy represents time and money not being used to ameliorate the opioid crisis. That's why we are moving as quickly as possible to deliver a settlement," Michele Sharp, a Purdue spokesperson, told The Wall Street Journal.

More articles on pharmacy:
'Enough is enough': APhA CEO calls for pharmacy reimbursement overhaul
Pfizer, BioNTech sign $1.95B vaccine distribution deal with the US
10 drugmakers expected to make the most money in the next 5 years

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Content

Featured Webinars

Featured Whitepapers